Insurers Claim Mallinckrodt Inflated Acthar Price By $300M
A pair of health insurers told a Delaware bankruptcy judge Monday that Mallinckrodt PLC owes them more than $300 million because of the drugmaker's alleged efforts to keep a cheaper alternative...To view the full article, register now.
Already a subscriber? Click here to view full article